NCT00003757View on ClinicalTrials.gov

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2007

Conditions
Leukemia
Interventions
BIOLOGICAL

rituximab

Trial Locations (1)

CH-8008

Klinik Hirslanden, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00003757 - Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy | Biotech Hunter | Biotech Hunter